Literature DB >> 10502315

Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis.

A M Rijken1, J Hu, E J Perlman, L A Morsberger, P Long, S E Kern, R H Hruban, C J Yeo, C A Griffin.   

Abstract

We report genomic abnormalities identified in 14 human primary common bile duct carcinomas analyzed by cytogenetics or comparative genomic hybridization, or both. Combining the results of the two methods of analysis, 11 chromosomal arms were observed to be gained in whole or in part, and 9 chromosomal arms were lost in whole or in part in at least four tumors each. The most frequently lost chromosomal regions were, in decreasing order: 18q (eight tumors); 6q and 10p (seven tumors each); 8p, 12q, and 17p (six tumors each); and 7q, 12p, and 22q (four tumors each). The most frequently gained regions were 8q and 20q (six tumors each); 12p, 17q, and Xp (five tumors each); and 2q, 6p, 7p, 11q, 13q, and 19q (four tumors each). These results are similar to those we have previously reported in pancreatic cancer and suggest that carcinomas of the common bile duct and pancreas share a number of genetic changes. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502315

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 2.  The significance of genetics for cholangiocarcinoma development.

Authors:  Luca Maroni; Irene Pierantonelli; Jesus M Banales; Antonio Benedetti; Marco Marzioni
Journal:  Ann Transl Med       Date:  2013-10

3.  Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.

Authors:  Stephen J McPherson; Shirin Hussain; Preetika Balanathan; Shelley L Hedwards; Birunthi Niranjan; Michael Grant; Upeksha P Chandrasiri; Roxanne Toivanen; Yuzhuo Wang; Renea A Taylor; Gail P Risbridger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

4.  Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.

Authors:  Vikram Deshpande; Ioannis T Konstantinidis; Carlos Fernandez-Del Castillo; Aram F Hezel; Kevin M Haigis; David T Ting; Nabeel Bardeesy; Lipika Goyal; Andrew X Zhu; Andrew L Warshaw; Keith D Lillemoe; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2016-03-08       Impact factor: 3.452

5.  Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

Authors:  Jordan M Winter; Angela H Ting; Felip Vilardell; Eike Gallmeier; Steve B Baylin; Ralph H Hruban; Scott E Kern; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

6.  Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11.

Authors:  Patrick S Moore; Edoardo Missiaglia; Stefania Beghelli; Emma Bragantini; Maria M Mina; Giuseppe Zamboni; Massimo Falconi; Aldo Scarpa
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-16       Impact factor: 4.553

7.  CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.

Authors:  Jian-Hua Yu; Xiang-Yu Zhong; Wei-Guang Zhang; Zhi-Dong Wang; Qin Dong; Sheng Tai; Hui Li; Yun-Fu Cui
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

8.  Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.

Authors:  Matteo Fassan; Domenico D'Arca; Juraj Letko; Andrea Vecchione; Marina P Gardiman; Peter McCue; Bernadette Wildemore; Massimo Rugge; Dolores Shupp-Byrne; Leonard G Gomella; Andrea Morrione; Renato V Iozzo; Raffaele Baffa
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

9.  Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Chiara Varamo; Laura Casorzo; Carmine Dell'Aglio; Paola Bernabei; Giovanna Chiorino; Massimo Aglietta; Francesco Leone
Journal:  Tumour Biol       Date:  2015-10-20

10.  MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer.

Authors:  A Vecchione; M Fassan; V Anesti; A Morrione; S Goldoni; G Baldassarre; D Byrne; D D'Arca; J P Palazzo; J Lloyd; L Scorrano; L G Gomella; R V Iozzo; R Baffa
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.